“Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s509. Accessed April 13, 2025. https://skin.dermsquared.com/skin/article/view/3154.